SI2874635T1 - Terapevtski sestavki bakteriofagov - Google Patents

Terapevtski sestavki bakteriofagov

Info

Publication number
SI2874635T1
SI2874635T1 SI201331692T SI201331692T SI2874635T1 SI 2874635 T1 SI2874635 T1 SI 2874635T1 SI 201331692 T SI201331692 T SI 201331692T SI 201331692 T SI201331692 T SI 201331692T SI 2874635 T1 SI2874635 T1 SI 2874635T1
Authority
SI
Slovenia
Prior art keywords
bacteriophage compositions
therapeutic bacteriophage
therapeutic
compositions
bacteriophage
Prior art date
Application number
SI201331692T
Other languages
English (en)
Inventor
David Harper
Katy Blake
Original Assignee
Armata Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1207910.9A external-priority patent/GB201207910D0/en
Priority claimed from GBGB1218083.2A external-priority patent/GB201218083D0/en
Application filed by Armata Pharmaceuticals, Inc. filed Critical Armata Pharmaceuticals, Inc.
Publication of SI2874635T1 publication Critical patent/SI2874635T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
SI201331692T 2012-05-04 2013-05-03 Terapevtski sestavki bakteriofagov SI2874635T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1207910.9A GB201207910D0 (en) 2012-05-04 2012-05-04 Therapeutic bacteriophage compositions
GBGB1218083.2A GB201218083D0 (en) 2012-10-09 2012-10-09 Therapeutic bacteriophage compositions
PCT/GB2013/051163 WO2013164640A1 (en) 2012-05-04 2013-05-03 Therapeutic bacteriophage compositions
EP13722007.5A EP2874635B1 (en) 2012-05-04 2013-05-03 Therapeutic bacteriophage compositions

Publications (1)

Publication Number Publication Date
SI2874635T1 true SI2874635T1 (sl) 2020-07-31

Family

ID=48428494

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201331692T SI2874635T1 (sl) 2012-05-04 2013-05-03 Terapevtski sestavki bakteriofagov

Country Status (8)

Country Link
US (2) US10124027B2 (sl)
EP (2) EP3656390B1 (sl)
JP (1) JP6250639B2 (sl)
AU (1) AU2013255583B2 (sl)
CA (2) CA3082772C (sl)
ES (2) ES2969034T3 (sl)
SI (1) SI2874635T1 (sl)
WO (1) WO2013164640A1 (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3082772C (en) 2012-05-04 2023-05-02 Armata Pharmaceuticals, Inc. Therapeutic bacteriophage compositions
US20170268031A1 (en) * 2014-07-30 2017-09-21 The Regents Of The University Of California Methods for bacteriophage detection
US11058131B2 (en) 2015-04-16 2021-07-13 Kennesaw State University Research And Service Foundation, Inc. Escherichia coli O157:H7 bacteriophage Φ241
US10517908B2 (en) 2015-08-13 2019-12-31 Armata Pharmaceuticals, Inc. Therapeutic bacteriophage compositions
WO2018146437A1 (en) 2017-02-13 2018-08-16 Biocontrol Limited Therapeutic bacteriophage compositions
KR102011965B1 (ko) * 2017-06-19 2019-08-19 주식회사 마이크로바이오틱스 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지
KR102011956B1 (ko) * 2017-06-19 2019-08-19 주식회사 마이크로바이오틱스 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지
KR101940019B1 (ko) * 2017-06-19 2019-01-18 연세대학교 산학협력단 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지
KR102264514B1 (ko) * 2017-06-19 2021-06-18 주식회사 마이크로바이오틱스 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지
KR102193473B1 (ko) * 2017-12-27 2020-12-28 주식회사 옵티팜 신규한 클렙시엘라 속 세균 특이 박테리오파지 kp12 및 이를 포함하는 항균 조성물
CN112218659A (zh) 2018-01-02 2021-01-12 阿玛塔制药股份有限公司 用于治疗葡萄球菌感染的治疗性噬菌体组合物
CN112243377A (zh) 2018-02-07 2021-01-19 阿玛塔制药股份有限公司 用于治疗和预防细菌相关的癌症的噬菌体
CN113875781A (zh) * 2021-09-06 2022-01-04 河南兴华生物技术有限公司 一种模拟养殖场区利用噬菌体抑制巴氏杆菌的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470361A (en) 1967-12-28 1969-09-30 Enm Co Counter
GB1218083A (en) 1968-06-17 1971-01-06 Ici Ltd Process for separating and recovering acid gases from gaseous mixtures
WO2002086154A2 (en) 2001-04-19 2002-10-31 Biophage, Inc. Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages
DE60315636T2 (de) 2002-03-25 2008-05-08 University Of Warwick, Coventry Zur therapie und prophylaxe bakterieller infektionen geeignete bakteriophagen
EP1663265B1 (en) 2003-07-23 2015-09-23 Biocontrol Limited Bacteriophage-containing therapeutic agents
BRPI0517957B1 (pt) 2004-11-01 2018-12-26 Strategic Diagnostics Inc método para enriquecer, composição e kit para detectar um microrganismo alvo em uma amostra
EP2103308A1 (de) * 2008-03-20 2009-09-23 PhytoLine GmbH Verfahren zur Herstellung eines Gemisches von Bakteriophagen und deren Verwendung für die Therapie von Antibiotika-resistenten Staphylococcen
US9486007B2 (en) 2008-03-25 2016-11-08 Ecolab Usa Inc. Bacteriophage treatment for reducing and preventing bacterial contamination
TWI432306B (zh) 2008-07-08 2014-04-01 Gala Inc 利用熱及大氣壓控制之熱塑材料給料系統以達成配方及反應聚合作用之方法及裝置
JP5720045B2 (ja) * 2008-12-26 2015-05-20 国立大学法人東京工業大学 スタフィロコッカス・アウレウス溶菌性バクテリオファージ
RU2580248C9 (ru) * 2009-02-06 2018-01-17 Текнофахе, Инвестигасао Э Десенвольвименто Эм Биотекнолохия, Са Бактериофаг, обладащий активностью против pseudomonas aeruginosa, белки бактериофага и способы их применения
KR20100093626A (ko) 2009-02-17 2010-08-26 서강대학교산학협력단 슈도모나스 애루지노사에 대한 파아지 치료
CA3082772C (en) 2012-05-04 2023-05-02 Armata Pharmaceuticals, Inc. Therapeutic bacteriophage compositions

Also Published As

Publication number Publication date
CA3082772A1 (en) 2013-11-07
CA3082772C (en) 2023-05-02
US20180289756A1 (en) 2018-10-11
AU2013255583A1 (en) 2014-11-06
EP2874635B1 (en) 2019-12-18
CA2871986C (en) 2020-11-03
JP6250639B2 (ja) 2017-12-20
ES2773149T3 (es) 2020-07-09
JP2015523850A (ja) 2015-08-20
EP3656390B1 (en) 2023-10-18
US10124027B2 (en) 2018-11-13
ES2969034T3 (es) 2024-05-16
EP2874635A1 (en) 2015-05-27
US20150118191A1 (en) 2015-04-30
WO2013164640A1 (en) 2013-11-07
EP3656390A1 (en) 2020-05-27
AU2013255583B2 (en) 2017-10-12
CA2871986A1 (en) 2013-11-07

Similar Documents

Publication Publication Date Title
HK1213798A1 (zh) 治療性化合物和組合物
HK1203963A1 (en) Novel therapeutic agents
HK1206297A1 (en) Pharmaceutical compositions for combination therapy
HK1209638A1 (en) Pharmaceutical compositions
SI2874635T1 (sl) Terapevtski sestavki bakteriofagov
ZA201501930B (en) Pharmaceutical composition
EP2832730A4 (en) MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION
HRP20190050T1 (hr) Farmaceutski pripravci za kombinacijsku terapiju
EP2897613A4 (en) TREATMENT COMPOSITIONS
GB201420971D0 (en) Therapeutic composition
IL217807A0 (en) Therapeutic compositions
ZA201502987B (en) Pharmaceutical composition
EP2897590A4 (en) PHARMACEUTICAL COMPOSITION
EP2804853A4 (en) THERAPEUTIC USES
GB201211153D0 (en) Pharmaceutical compositions
EP2851078A4 (en) PHARMACEUTICAL COMPOSITION
GB201218083D0 (en) Therapeutic bacteriophage compositions
GB201207910D0 (en) Therapeutic bacteriophage compositions
IL238075A0 (en) pharmaceutical preparations
IL236873A0 (en) therapeutic compounds
GB201214237D0 (en) Novel therapeutic composition
ZA201405764B (en) Novel therapeutic agents
ZA201400751B (en) Pharmaceutical composition
GB201219234D0 (en) Pharmaceutical compositions
GB201213303D0 (en) Pharmaceutical compositions